As a key player in the Hungarian pharmaceutical industry, Egis is voluntarily joining the initiative of the Ministry of National Economy aimed at curbing the price increases of Reparon Ointment 30g. More
Egis´ products are sold to more than 100 countries.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
One of the fundamental pillars of our strategy is innovation.
Our highlighted past and future events you shouldn't miss
Egis World
Egis´ products are sold to more than 100 countries.

Csaba Poroszlai at the conference on the competitiveness of the European and Hungarian pharmaceutical industry

Under the patronage of Márton Nagy, Minister of National Economy, the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) held its annual conference, focusing on enhancing the competitiveness of the domestic and European pharmaceutical industry. In his speech, the minister emphasized that the pharmaceutical industry is a historical sector in Hungary and a crucial pillar of growth.

More

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

• mAbxience and Egis collaborate on the commercialization of two biosimilar candidates • The agreement covers eight Central and Eastern European countries with the potential for expansion into additional territories • mAbxience will serve as the marketing authorization holder, while Egis will manage commercialization in the designated regions

More

Ten Years Together – Egis Pharmaceuticals PLC Remains the Partner of the Körmend Basketball Team

The red-black team of the Vas county town and one of the largest Hungarian pharmaceutical companies have extended their cooperation for another year. The team will continue to play under the name Egis Körmend in the championship.

More

This was the year we commemorated the 110th anniversary of the foundation of our company

Continuous modernisations and investment, launch of a new line of business, tree planting, exhibitions, and a short story contest. In 2023 Egis commemorated its 110th anniversary with a special series of events.

More
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life

Egis is recognised as a Top Employer 2025 in Hungary

Egis Pharmaceuticals Plc. applied for the prestigious Top Employer Hungary certification for the first time and successfully joined the ranks of companies recognized for their outstanding employer practices on an international level.

More

Egis Pharmaceuticals Plc. Expands Its Portfolio with a Well-Known Product Line

Egis Pharmaceuticals has announced that, backed by the Hungarian Competition Authority´s official certification, it has acquired one of Hungary´s well-known, locally applied dermatological product lines from Teva Pharmaceutical Industries Ltd. This move aims to strengthen Egis´s position in the Hungarian over-the-counter (OTC) market.

More

110 years in 210 seconds

Throughout the year our company has celebrated the 110th anniversary of its foundation. Not only several initiatives have been launched to commemorate this notable event, but the jubilee year also presented a great opportunity to look back on the past eleven decades of our company.

More

More employer recognition award for our team in Poland

Egis Polska received Friendly Workplace Award and Great Place to Work title

More
Innovation
One of the fundamental pillars of our strategy is innovation.

Development of Innovative, High Value-Added Oncological Drug Products for Personalized Therapies

he project identified as 2020-1.1.2-PIACI-KFI-2020-00039, conducted by Egis Pharmaceuticals PLC and its consortium partner, the HUN-REN Research Centre for Natural Sciences (TTK), finished on December 31, 2024.

More

Egis' medicines won the Innovation Grand Prize

Two of Egis’ fixed-dose combination drugs have won the Innovation Grand Prize. The awarded Egis medicines feature significant innovations as they reduce the risk of cardiovascular events related to atherosclerosis due to the combined lipid-lowering therapy. In respect of these two products the company obtained three patents related to active ingredient development and two patents related to formulation development that are all relevant to large-scale manufacturing technologies. The recognition was not without a history, as this is the tenth time an Egis medicine has received an Innovation Prize or Grand Prize.

More

Egis expands its portfolio with active pharmaceutical ingredient contract development and contract manufacturing

Egis Pharmaceuticals PLC, celebrating the 110th anniversary of its foundation this year, is expanding its usual activities with new elements thanks to investments exceeding a total value of more than HUF 100 billion in Hungary over the past decade.  Egis, one of the leading generic pharmaceutical companies in Eastern and Central Europe, now offers drug substance contract development and contract manufacturing services under the name of Egis Pharma Services to both existing and new pharmaceutical partners.

More

National Science and Innovation Olympiad with Egis’ backing

We are proud to have contributed to the recognition of the most innovative young people.

More
Events
Our highlighted past and future events you shouldn't miss

The 2024 Hungarian Innovation Grand Prize Contest was announced at Egis

The Hungarian Innovation Association, in collaboration with the Hungarian Innovation Foundation, announced the contest for the 2024 Innovation Grand Prize at the Egis Science and Technology Center. The significance of the award is highlighted by the fact that innovative companies can apply for the 33rd time for the competition, which will conclude with a ceremonial award ceremony next spring.

More

Chemistry for Everyone: Cross-Industry Collaboration

In Hungary, industries closely related to chemistry – the chemical industry, pharmaceutical industry, and environmental industry – have significant national economic weight, yet these sectors face above-average labor shortages.

More

Night of Museums at Egis’ visitor centre

On the Night of Museums, our programme was quite a popular one: we had more than 120 visitors on this special night. The places were snapped up so quickly that after a few days, we had to close the registration.

More

More than 100 visitors on the Night of Museums at Egis!

On the Night of Museums, we welcomed visitors in three groups in the Egis Science and Technology Centre. Many people expressed their interest in the everyday life of a pharmaceutical company and places were snapped up so quickly that after a few days we had to close the registration.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox